| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.32 | 0.06 |